EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$167M
(+14%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
ConocoPhillips
COP
$115B
| $226K | 0.02% |
2,280
-133
| -6% | -$13.2K |
|
277
Emergent Biosolutions
EBS
$409M
| $225K | 0.02% |
21,746
-20
| -0.1% | -$207 |
|
278
Lowe's Companies
LOW
$151B
| $225K | 0.02% |
1,127
-75
| -6% | -$15K |
|
279
Myriad Genetics
MYGN
$624M
| $224K | 0.02% |
9,639
-1,183
| -11% | -$27.5K |
|
280
Boeing
BA
$172B
| $223K | 0.02% |
1,048
-26
| -2% | -$5.53K |
|
281
Caterpillar
CAT
$197B
| $222K | 0.02% |
970
-46
| -5% | -$10.5K |
|
282
Hewlett Packard
HPE
$30.6B
| $220K | 0.02% |
13,833
+781
| +6% | +$12.4K |
|
283
Arcturus Therapeutics
ARCT
$486M
| $217K | 0.02% |
+9,073
| New | +$217K |
|
284
Replimune Group
REPL
$477M
| $217K | 0.02% |
+12,305
| New | +$217K |
|
285
Prologis
PLD
$105B
| $215K | 0.02% |
1,720
-56
| -3% | -$7K |
|
|
VERV
286
DELISTED
Verve Therapeutics
VERV
| $215K | 0.02% |
14,936
-4,587
| -23% | -$66K |
|
287
Morgan Stanley
MS
$236B
| $214K | 0.02% |
2,434
-141
| -5% | -$12.4K |
|
288
S&P Global
SPGI
$163B
| $212K | 0.02% |
614
-31
| -5% | -$10.7K |
|
289
CareDx
CDNA
$738M
| $211K | 0.02% |
23,122
-2,333
| -9% | -$21.3K |
|
290
Humana
HUM
$37.3B
| $211K | 0.02% |
435
-15
| -3% | -$7.28K |
|
291
VeriSign
VRSN
$26.1B
| $209K | 0.02% |
+989
| New | +$209K |
|
292
Deere & Co
DE
$128B
| $208K | 0.02% |
504
-31
| -6% | -$12.8K |
|
293
HCA Healthcare
HCA
$97.9B
| $207K | 0.02% |
786
-76
| -9% | -$20K |
|
294
Goldman Sachs
GS
$223B
| $206K | 0.02% |
631
-26
| -4% | -$8.49K |
|
|
DCPH
295
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $205K | 0.02% |
13,288
+49
| +0.4% | +$756 |
|
296
Edwards Lifesciences
EW
$47.4B
| $203K | 0.01% |
+2,449
| New | +$203K |
|
297
Skyworks Solutions
SWKS
$11.1B
| $203K | 0.01% |
+1,717
| New | +$203K |
|
298
Zentalis Pharmaceuticals
ZNTL
$125M
| $203K | 0.01% |
11,821
-195
| -2% | -$3.35K |
|
299
Karyopharm Therapeutics
KPTI
$57.7M
| $202K | 0.01% |
3,457
+1,023
| +42% | +$59.8K |
|
300
Xencor
XNCR
$611M
| $201K | 0.01% |
+7,213
| New | +$201K |
|